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Immunorcactive (IR) proTRH forms were characterized in human hypothalamic tissue with two antisera raised against a hcpta- and a deeapepdde 
containing the TRH progenitor sequence (-Gin-His-Pro-Gly-). A similar study was performed in human normal and adenomatous anterior 
pituitaries, tissues in which TRH synthesis has been previously suggested. IR-proTRH was found in all the samples ranging from 42-775 fmoUmg 
proteins. Size exclusion chromatography idcntiticd a major 25-35 kDa form and a minor 4-8 kDa form. The existence of the major form was 
confimled by immunoblotting. The results uggest that both human hypothalamic and normal or adenomatous anterior pituitary tissues ynthesize 
similar lR-proTRH forms. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Thyroliberin (TRH) is a tripeptide, initially identified 
in mammalian hypothalamus, that is widely distributed 
throughout he body and is synthesized in extrahypo- 
thalamic tissues [l-3], It has also been observed in the 
rat anterior pituitary and in the human normal and 
adenomatous pituitary [4-61 and its synthesis by these 
tissues has been envisaged [‘WI. Like other peptides, 
TRW is produced through the processing of a high mo- 
lecular weight precursor. The structure of this 
preproTRH has been deduced from the cDNA sequence 
established in the xenope [lO,ll], rat and man [12,13]. 
Human preproTRH contains six TRH progenitor se- 
quences (-Gin-His-Pro-Gly-), each flanked by pairs of 
basic amino acids. Precursor forms of different molecu- 
lar weights (2.5-52 kDa) have been partially charac- 
terized in rat and mouse brain by immunochemical 
methods [14,163. 
This work provides evidence for the presence of IR- 
proTRH forms in human hypothalamus, normal and 
tumoral anterior pituitaries. Their partial characteriza- 
tion was performed by size exclusion chromatography, 
immunoenzymatic assay and immunoblotting, using 
two antisera against extended TRH progenitor se- 
quences. 
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Six human pituitary adcnomas (2 prolactinomas, 2 GH-secreting 
and 2 non-secreting adcnomas) were collected in the operating room 
after trans.sphenoidal denomectomy and frozen in liquid nitrogen 
until use. One normal pituitary and fragments of one hypothalamus 
were obtained 6 II post-mortem from 2 patients presenting no neurocn- 
docrine disorder. 
2.2. Esrractiorts aud six csclusiot~ chrorrratography 
Tissue fragments were immersed in 1 M acetic acid at 95°C for 5 
min (l:lO. w/v), then homogenized in a Potter apparatus and cen- 
trifuged at 5.009 x g for 30 min at 4OC as previously dffcribed [14]. 
The pellet was stored at -20°C until protein assay while the super- 
natant was lyophilized. The lyophilized extracts were resuspended in 
I M acetic acid ancl filtered through a GW sephadcx column (100 x 1.6 
cm, Bio-Rad) equihbratecl and eluted with I M acetic acid at 4°C at 
a rate of 12 ml/h. 2 ml fractions were collected, aliquoted and lyophil- 
ized for proTRH and TRH assays. 
2.3. RIA of TRH 
RIA of TRH was performed as previously described [lfl. The min- 
imum amount of TRH that was detected was 4 fmol. 
2.4. Itrr~nuno~n:yt~tutfc ssuy oJproTRH Jorm 
This was performed according to [IS] using a mbbit antibody 
directed against the PI0 peptide. an extended TRH progenitor se- 
quence (Ser.Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-Phe). AXtOUnt5 of 
IR-proTRH were expressed in lcrms of IR-PIO. The sensitivity 
threshold of the assay was 2 fmol. 
2.5. f~nmmblottbg of proTAN forms 
The acidic cxtrdcts wem analyzed by sodium dodecyl sulfate. 14% 
polyacrylamide gel clectrophoresis [19]. Proteins were transferred to 
an immobilon P membrane for 18 It in 25 mM Tris, 192 mM glycine 
and 20% methanol, pH 8.3 [20]. The mcmbranc was saturated for 90 
min in 50 mM Tris bufiitr, 9% NaCI, pH 7.4, con-mining 39% skin~.d 
milk, The immunological reactions wcrc performed using a rabbit 
antibody directed against the P7 peptide, another extended TRH pro- 
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gcnitor sequence (Gin-His-Pro-Gl~Lys-Arg-Phe). at a l:l,OOO dilu- 
tion for 24 h at 4%. The antigen-antibody complex was revealed with 
‘~51-labelled anti-rabbit immunoglobulin G antibody (Amcrsham), 
The membrane was exposed to film (Hypcrfilmpmax. Amersham) for 
5 days. 
3. RESULTS 
3.1. TRH and IR-PI0 contents 
As previously described [9], the amount of TRH 
widely varied from one adenoma to another. TRH con- 
tents in the normal anterior pituitary and the adenomas 
were in the same range, 17 and 3 to 83 fmol/mg proteins, 
respectively (Table I). It was much higher in the hypo- 
thalamus (I ,802 fmollmg proteins). 
The values of IR-PI0 concentrations in the anterior 
pituitary tissues were relatively grouped except in one 
prolactinoma (case I, Table II) in which the concentra- 
tion was much higher (775 fmol/mg proteins) than in the 
other samples (1X-241 fmol/mg proteins). By contrast, 
IR-PlO content was lower in the hypothalamus (42 
fmol/mg proteins). 
The ratio, TRH/IR-PIO, was far lower in tumoral and 
normal pituitaries (Table II, 0.02-0.53 and 0.14, respec- 
tively) than in the hypothalamus (43.95). 
3.2. IR-PI0 after elurion on Sephudex G,, 
Two peaks of IR-PI0 were constantly observed after 
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gel filtration of acidic extracts from all the tumoral and 
normal anterior pituitaries as well as from the hypo- 
thalamus (Fig, 1). The first peak eluted at a position 
corresponding to a molecular weight of 25-35 kDa. The 
second peak corresponded to a 4-8 kDa molecular 
weight. The respective sizes of the two peaks were vari- 
able from one adenoma to the other. The surface of the 
25-35 kDa peak was larger than that of the 4-8 kDa 
peak in most adenomas, 21s well as in the normal an- 
terior pituitary and the hypothalamus. However in two 
adenomas (cases I and 5), the major peak consisted of 
the 4-8 kDa form (Table II). 
3.3. htnrmoblottitg 
The immunoblotting of acidic extracts of the hypo- 
tha!,amus and two adenomas (cases 4 and 5), using the 
anti-P7 antibody, revealed the presence of a strongly 
immunoreactive band corresponding to a molecular 
weight of 37 kDa (Fig. 2). This band was absent when 
the anti-P7 antibody pre-absorbed with P7 was used. 
4. DISCUSSION 
Our results are the first evidence for the presence of 
immunoreactive, high molecular weight TRH precursor 
forms (25-35 and 68 kDa) in human tissues. The anti- 
sera used in this study were developed to identify TRH 
precursor forms in murine brain [16]. These antisera 
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Fig0 1. IR-PlO in Glo Sephadex chromatogruphy fractions corresponding to 2 mg of proteins of crude extract, (A) human hypothalamus (case 8). 
(B) human on-secreting adenomlr (case 6). The molecular weight markers shown arc: CA, carbonic anhydrase, 29 kDa; Try, lrypsinogcn, 
PMSF-treated, 23 kDa; Lac, a-lactalbumin, 14.2kDa; Apr, Aprotinin, 6.5 kDa; and [1z51]THR. Vo, void volume. 
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Fig. 2. Immunoblotting of a human non.sccreting adcnoma (case 5) 
performed with anti-P7 antibody (lane B) or preabsorbed an&P? 
antibody (lane A). Molecular weight markers: ovalbumin. 46 kDu; 
carbonic anhydrasc 30 kDa; trypsin inhibitor, 21.5 kDa; and ly 
sozymc. 14.3 kDa, 
have been shown [ 173 not to cross-react with TRH itself, 
with connecting peptides resulting from proTRH 
processing [21], or with TRH-Gly, the direct precursor 
of TRW [3]. The cross-reactivity of the antisera with 
both human and murine TRH precursors resulted from 
extended sequence homologies between the two pre- 
cursors, above all at the level of the TRH progenitor 
sequences and the surrounding amino acids [12,13]. The 
two antisera used here were raised against such highly 
homologous regions. The 25-35 kDa form is com- 
patible with that of the 24%residue protein that could 
be encoded by the human preproTRH mRNA [ 133. The 
4-8 kDa form might represent an intermediate step of 
the processing yielding a product containing a progcn- 
itor sequence still attached to a connecting peptide, al- 
though an artefactual degradation of the large form 
cannot be excluded. 
In addition to significant amounts of TRH, anterior 
pituitary tissues contained IR-proTRM forms similar to 
Table r 
TRH and IR-PI0 contents in human hypothalamus, normal and 
adcnomatous anterior pituitary 
IR-PIO* TRH* TRH 
IR-PIO 
Adenomas (II = G) 285 + 243 42+ 31 0.21 + 0.20 
Normal anterior 
pituitary (n = I) 120 I7 0.14 
Hypothalamus (II = I) 42 1.802 43.95 
*Results expressed in fmoVmg proteins. 
Table If 
IR-PI0 contenls in human anterior pituitary tissues and hype- 
thalamus: distribution into the two peaks after size exclusion chroma- 
tography 
IR.PIO in crude 1st peak 2nd peak 
extracts’; (25-35 kDa*) (4-8 kDa)* 
Prolactinomas 
#I 775 135 550 
#2 234 139 88 
GH+ccreting 
adcnomas 
#3 241 163 54 
#4 163 135 23 
Nonsecreting 
adcnomas 
#5 158 33 13 
#B 139 66 36 
Normal anterior 
pituitary 
#I 120 44 70 
Hypothalamus 
#8 42 25 16 
*Results expressed in fmollmg proteins. 
those found in the hypothalamus. However, the TRH/ 
IR-proTRH ratio was much higher in the hypo- 
thalamus than in the anterior pituitary tissues. The 
sharp increase of the TRHAR-proTRH ratio that has 
been reported in the mouse hypothalamus during fetal 
development might reflect ontogenic alterations of the 
processing of proTRH [163. 
To conclude, our data identify the human normal and 
tumoral anterior pituitary as a novel site of TRH syn- 
thesis and suggest that the maturation process of 
proTRH in the anterior pituitary is different from that 
occurring in the hypothalamus. 
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